Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GSK 3532795

Next Previous
X
Search
Drug Profile

GSK 3532795

Alternative Names: BMS 955176; GSK-3532795; HIV maturation inhibitor - GSK/ViiV Healthcare

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bristol-Myers Squibb
  • Developer GlaxoSmithKline; Senopsys; ViiV Healthcare
  • Class Amines; Antivirals; Benzoic acids; Chrysenes; Cyclopentanes; Small molecules; Thiazines
  • Mechanism of Action HIV replication inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued HIV-1 infections

Most Recent Events

  • 25 Sep 2017 Bristol-Myers Squibb terminates a phase II trial due to GI intolerability in HIV-1 infections (Combination therapy, Treatment-experienced) in USA, Puerto Rico, Australia, Chile, Mexico, Taiwan, Argentina, Canada, Colombia, Peru, Russia, South Africa, and Thailand (PO) (NCT02386098)
  • 21 Aug 2017 Bristol-Myers Squibb terminates phase II trial in HIV-1 infections (Combination therapy, Treatment-naive) in USA, Argentina, Canada, Chile, Mexico, Puerto Rico, Poland, United Kingdom, France, Germany, Spain, Italy, South Africa and Thailand (NCT02415595)
  • 01 Mar 2017 ViiV Healthcare withdraws a phase I trial in volunteers in USA prior to enrolment, due to neuropsychiatric serious adverse events reported by two participants (NCT02576119)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top